ECS Botanics Holdings Ltd (ASX:ECS)

bluebird bio Revenue

ECS Botanics Holdings had revenue of 9.73M AUD in the half year ending December 31, 2024, with 43.07% growth. This brings the company's revenue in the last twelve months to 18.48M, down -6.99% year-over-year. In the fiscal year ending June 30, 2024, ECS Botanics Holdings had annual revenue of 20.03M with 30.16% growth.

• Revenue (ttm): 18.48M
• Revenue Growth: -6.99%
• P/S Ratio: 0.60
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 11.02M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	20.03M	4.64M	30.16%
Jun 30, 2023	15.39M	10.09M	190.43%
Jun 30, 2022	5.30M	3.92M	285.34%
Jun 30, 2021	1.38M	455.92K	49.60%
Jun 30, 2020	919.13K	900.39K	4,803.85%